#DoxTM
LightNews LightNews
4040rec.bsky.social
#rarediseases #MHRA #UK #PIMdesignation #UCB #DoxTM #TK2d #ThymidineKinase2Deficiency #TK2Deficiency #patientaccess #TK2geneticmutation #mitochondrialDNAdepletion #EarlyAccesstoMedicines #EAMS #MitochondrialMedicine #Mitochondrialdiseases
pharmatimes.com/news/mhra-gr...
MHRA grants Promising Innovative Medicine designation to UCB’s DoxTM for TK2d - PharmaTimes
UCB’s developmental treatment may be eligible for patient access
pharmatimes.com
May 12, 2025 at 9:46 AM
longtail-news.bsky.social
Feed: "PharmaTimes"
By: John Pinching on Wednesday, May 7, 2025
MHRA grants Promising Innovative Medicine designation to UCB’s DoxTM for TK2d
UCB’s developmental treatment may be eligible for patient access
pharmatimes.com
May 7, 2025 at 3:22 PM